NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/02/2025
Back to search
Official data from USPTO
COLOALERT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
COLOALERT
ST13
US500000097375172Class
5, 9, 10, 42, 44
Filing
97375172
Registration
8045573
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
12/03/2025
Trademark type
Word
Nice classes
5, 9, 10, 42, 44
Filing date
04/21/2022
Registration date
12/02/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/02/2025
Last transaction
12/03/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Mainz, DE
Examiner
KLUWE,CHERYL D
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Mainz Biomed N.V.
Representatives
Eric R. Moran MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemically treated papers for use in the detection of fecal occult blood; Chemical preparations for use in DNA analysis for medical purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic agents for pharmaceutical use; Diagnostic preparations for veterinary purposes; Diagnostic biomarker reagents for medical purposes; In vitro diagnostic preparations for medical use; Medical diagnostic test strips for blood analysis; Medical diagnostic reagents and assays for testing of body fluids and excreta; Preparations for detecting genetic predispositions for medical purposes; Reagents for analytical purposes for medical purposes; Reagents for in-vitro laboratory use for medical purposes; Reagents and media for medical and veterinary diagnostic purposes; Reagents for use in analysis for medical purposes; Reagents for use in diagnostic tests for medical purposes; Reagents for use in medical genetic testing; Reagents for medical use; Reagents for use in veterinary genetic testing; Diagnostic preparations and materials for medical purposes; Diagnostic test kits comprised of medical diagnostic reagents and assays for the detection of diseasescancercolorectal cancer
Class 9
Downloadable and recorded electronic databases for use in the medical field; Data setsrecorded or downloadablefor use in the medical field; Downloadable and recorded computer software for data processing; Downloadable and recorded computer software for use in database managementelectronic storage of datadata processingrelating to the medical field; Downloadable and recorded computer software to enable the searching of data; Downloadable and recorded computer software for use in medical decision support systems for database managementelectronic storage of datadata processing
Class 10
Medical diagnostic apparatus for testing cancer cells; Medical diagnostic apparatus for testing for cancercolorectal cancer for medical purposes; Diagnostic apparatus for testing for cancercolorectal cancer for medical purposes; Diagnostic measuring apparatus for medical use for measuring biological samples; Tools for medical diagnostics for the analysis of biological samples; Medical diagnostic apparatus for analysing substances for detecting cancercolorectal cancer; Medical analytical apparatus for medical purposes for testing for cancercolorectal cancer; Genetic testing apparatus for medical purposes; Medical diagnostic apparatus for medical purposes for testing for cancercolorectal cancer; Measuring devices for medical use for measuring biological samples; Specimen samplers for medical usemedical specimen collection devices in the nature of containers for the collection of biological samples; Apparatus for medical cell sampling
Class 42
Biological research; Computer software design for others; Research and development of new products for others; Installation of computer software; Software as a service (SAAS) services featuring software for database managementelectronic storage of datadata processing; Technological consultancy services in the medical field; Rental of computers and computer software for database managementelectronic storage of datadata processing; Scientific research; Scientific laboratory services
Class 44
Medical laboratory services for the analysis of samples taken from patients for diagnostic and treatment purposes; DNA screening for medical purposes; RNA or DNA analysis services for the diagnosis and prognosis of diseases; Genetic counseling; Medical and healthcare services relating to DNAgenetics and genetic testing; Genetic testing for medical purposes; Genetic testing of animals for diagnostic or treatment purposes
Publications
History of USPTO decisions and trademark events.
42 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/02/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/14/2025
PUBO
PUBLISHED FOR OPPOSITION
10/14/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/08/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/18/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
09/18/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/18/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
09/18/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/18/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/17/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/17/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/17/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06/30/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06/30/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
03/30/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
03/30/2025
CNSI
SUSPENSION INQUIRY WRITTEN
03/30/2025
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/10/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/17/2024
GNSL
LETTER OF SUSPENSION E-MAILED
07/17/2024
CNSL
SUSPENSION LETTER WRITTEN
07/17/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/17/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/17/2024
ALIE
ASSIGNED TO LIE
07/17/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/30/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/07/2023
GNRT
NON-FINAL ACTION E-MAILED
11/07/2023
CNRT
NON-FINAL ACTION WRITTEN
11/07/2023
DOCK
ASSIGNED TO EXAMINER
09/05/2023
DOCK
ASSIGNED TO EXAMINER
08/28/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/08/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
05/12/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
05/12/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/16/2023
GNRT
NON-FINAL ACTION E-MAILED
02/16/2023
CNRT
NON-FINAL ACTION WRITTEN
02/16/2023
DOCK
ASSIGNED TO EXAMINER
02/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/27/2022
NWAP
NEW APPLICATION ENTERED
04/25/2022
Continuous trademark protection
Get notified about every new filing that threatens COLOALERT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.